The second product of IASO to receive IND approval from the FDA SHANGHAI and NANJING, China and SAN JOSE, Calif., June 17, 2023 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.